Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents
- PMID:27614411
- DOI: 10.1016/j.ejmech.2016.08.067
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents
Abstract
In the early 2000s, the Sigma Receptor (SR) family was identified as potential "druggable" target in cancer treatment. Indeed, high density of SRs was found in breast, lung, and prostate cancer cells, supporting the idea that SRs could play a role in tumor growth and progression. Moreover, a link between the degree of SR expression and tumor aggressiveness has been postulated, justified by the presence of SRs in high metastatic-potential cancer cells. As a consequence, considerable efforts have been devoted to the development of small molecules endowed with good affinity towards the two SR subtypes (S1R and S2R) with potential anticancer activity. Herein, we report the synthesis and biological profile of aryl-alkyl(alkenyl)-4-benzylpiperidine derivatives - as novel potential anticancer drugs targeting SR. Among them, 3 (RC-106) exhibited a preclinical profile of antitumor efficacy on a panel of cell lines representative of different cancer types (i.e. Paca3, MDA-MB 231) expressing both SRs, and emerged as a hit compound of a new class of SR modulators potentially useful for the treatment of cancer disease.
Keywords: Apoptotic pathway; Compound 3 (RC-106); Pan-SR modulators; Potential anticancer property; S1R agonist/antagonist profile; Sigma Receptor (SR).
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
- Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.Georgiadis MO, Karoutzou O, Foscolos AS, Papanastasiou I.Georgiadis MO, et al.Molecules. 2017 Aug 25;22(9):1408. doi: 10.3390/molecules22091408.Molecules. 2017.PMID:28841173Free PMC article.Review.
- Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.Piergentili A, Amantini C, Del Bello F, Giannella M, Mattioli L, Palmery M, Perfumi M, Pigini M, Santoni G, Tucci P, Zotti M, Quaglia W.Piergentili A, et al.J Med Chem. 2010 Feb 11;53(3):1261-9. doi: 10.1021/jm901542q.J Med Chem. 2010.PMID:20067271
- Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors.Zampieri D, Romano M, Fortuna S, Amata E, Dichiara M, Cosentino G, Marrazzo A, Mamolo MG.Zampieri D, et al.Molecules. 2024 Jun 6;29(11):2697. doi: 10.3390/molecules29112697.Molecules. 2024.PMID:38893570Free PMC article.
- Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).Collina S, Bignardi E, Rui M, Rossi D, Gaggeri R, Zamagni A, Cortesi M, Tesei A.Collina S, et al.Expert Opin Ther Pat. 2017 May;27(5):565-578. doi: 10.1080/13543776.2017.1276569. Epub 2017 Jan 13.Expert Opin Ther Pat. 2017.PMID:28051882Review.
- Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines.Rossi D, Rui M, Di Giacomo M, Schepmann D, Wünsch B, Monteleone S, Liedl KR, Collina S.Rossi D, et al.Bioorg Med Chem. 2017 Jan 1;25(1):11-19. doi: 10.1016/j.bmc.2016.10.005. Epub 2016 Oct 11.Bioorg Med Chem. 2017.PMID:27838169
Cited by
- PEG 400/Cerium Ammonium Nitrate Combined with Microwave-Assisted Synthesis for Rapid Access to Beta-Amino Ketones. An Easy-to-Use Protocol for Discovering New Hit Compounds.Rossino G, Raimondi MV, Rui M, Di Giacomo M, Rossi D, Collina S.Rossino G, et al.Molecules. 2018 Mar 28;23(4):775. doi: 10.3390/molecules23040775.Molecules. 2018.PMID:29597271Free PMC article.
- Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.Georgiadis MO, Karoutzou O, Foscolos AS, Papanastasiou I.Georgiadis MO, et al.Molecules. 2017 Aug 25;22(9):1408. doi: 10.3390/molecules22091408.Molecules. 2017.PMID:28841173Free PMC article.Review.
- Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response InIn Vitro Pancreatic Cancer Model.Cortesi M, Zamagni A, Pignatta S, Zanoni M, Arienti C, Rossi D, Collina S, Tesei A.Cortesi M, et al.Int J Mol Sci. 2020 Nov 27;21(23):9012. doi: 10.3390/ijms21239012.Int J Mol Sci. 2020.PMID:33260926Free PMC article.
- Recent advancements on the use of 2-methyltetrahydrofuran in organometallic chemistry.Monticelli S, Castoldi L, Murgia I, Senatore R, Mazzeo E, Wackerlig J, Urban E, Langer T, Pace V.Monticelli S, et al.Monatsh Chem. 2017;148(1):37-48. doi: 10.1007/s00706-016-1879-3. Epub 2016 Dec 7.Monatsh Chem. 2017.PMID:28127090Free PMC article.Review.
- Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer.Tesei A, Cortesi M, Pignatta S, Arienti C, Dondio GM, Bigogno C, Malacrida A, Miloso M, Meregalli C, Chiorazzi A, Carozzi V, Cavaletti G, Rui M, Marra A, Rossi D, Collina S.Tesei A, et al.Front Pharmacol. 2019 May 14;10:490. doi: 10.3389/fphar.2019.00490. eCollection 2019.Front Pharmacol. 2019.PMID:31156430Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous